Skip to main content
Top

2020 | OriginalPaper | Hoofdstuk

30. Endocriene tumoren

Auteurs : Prof. dr. G. D. Valk, Dr. R. S. van Leeuwaarde, Dr. M. J. C. van Treijen, Prof. dr. T. P. Links, Prof. dr. R. P. Peeters, Dr. H. J. L. M. Timmers, Dr. E. P. M. van der Kleij-Corssmit, Prof. dr. O. M. Dekkers, Dr. R. A. Feelders, Prof. dr. H. R. Haak, Prof. dr. N. R. Biermasz, Dr. J. Hofland, Prof. dr. W. W. de Herder, Prof. dr. A. M. Pereira Arias, Em. prof. dr. P. T. A. M. Lips, Prof. dr. J. W. A. Smit, Prof. dr. C. J. M. Lips, Dr. H. W. Kapiteijn, Prof. dr. J. Kievit, H. F. ten Kroode

Gepubliceerd in: Leerboek oncologie

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Het endocriene systeem verzorgt de informatie-uitwisseling in het lichaam voor het reguleren van de activiteit van cellen en weefsels. Endocrien actieve cellen komen in het hele lichaam voor. Binnen het endocriene systeem is er een klein aantal klassieke endocriene organen die hormonen produceren en afgeven. In de hersenen betreft dit de adenohypofyse die adrenocorticotroop hormoon (ACTH), thyroïdstimulerend hormoon (TSH), luteïniserend hormoon (LH), follikelstimulerend hormoon (FSH), prolactine en groeihormoon produceert; de neurohypofyse die antidiuretisch hormoon (ADH) en oxytocine produceert; de hypothalamus die ‘releasing’ en remmende hormonen produceert, die de functie van de hypofyse reguleren. In de rest van het lichaam zijn de klassieke endocriene organen de schildklier, de bijschildklieren, de bijnieren, de ovaria en testes en de pancreas. In de tractus digestivus en respiratorius zijn er diverse typen neuro-endocriene cellen die dienen als chemo- en mechanoreceptoren. Verder zijn organen die oorspronkelijk niet beschouwd werden als hormoonproducerend onderdeel van het endocriene systeem.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
go back to reference Correa R, Salpea P, Stratakis CA. Carney complex: an update. Eur J Endocrinol. 2015;173(4):M85–97. [Epub 2015 Jun 30]. Correa R, Salpea P, Stratakis CA. Carney complex: an update. Eur J Endocrinol. 2015;173(4):M85–97. [Epub 2015 Jun 30].
go back to reference De Laat JM, Tham E, Pieterman CR, Vriens MR, Dorresteijn JA, Bots ML, et al. Predicting the risk of multiple endocrine neoplasia type 1 for patients with commonly occurring endocrine tumors. Eur J Endocrinol. 2012;167(2):181–7. De Laat JM, Tham E, Pieterman CR, Vriens MR, Dorresteijn JA, Bots ML, et al. Predicting the risk of multiple endocrine neoplasia type 1 for patients with commonly occurring endocrine tumors. Eur J Endocrinol. 2012;167(2):181–7.
go back to reference Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, et al. Management of adrenal incidentalomas: European society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors. Eur J Endocrinol. 2016;175(2):G1–34. Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, et al. Management of adrenal incidentalomas: European society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors. Eur J Endocrinol. 2016;175(2):G1–34.
go back to reference Berruti A, Baudin E, Gelderblom H, et al. Adrenal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23(Suppl 7):8. Doi: mds231 [pii]. Berruti A, Baudin E, Gelderblom H, et al. Adrenal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23(Suppl 7):8. Doi: mds231 [pii].
go back to reference Bilezikian JP, et al. Hyperparathyroidism. Lancet. 2018;391(10116):168–78.CrossRef Bilezikian JP, et al. Hyperparathyroidism. Lancet. 2018;391(10116):168–78.CrossRef
go back to reference Buffet A, Burnichon N, Amar L, Gimenez-Roqueplo AP. Pheochromocytoma: when to search for a germline defect? Presse Med. 2018;47:e109–18.CrossRef Buffet A, Burnichon N, Amar L, Gimenez-Roqueplo AP. Pheochromocytoma: when to search for a germline defect? Presse Med. 2018;47:e109–18.CrossRef
go back to reference Caplin ME, Pavel M, Cwikla JB, et al. Lanreotide in metastatic enteropancreatic neuroendocrine tumors. N Engl J Med. 2014;371:224–33.CrossRef Caplin ME, Pavel M, Cwikla JB, et al. Lanreotide in metastatic enteropancreatic neuroendocrine tumors. N Engl J Med. 2014;371:224–33.CrossRef
go back to reference Casanueva FF, Barkan AL, Buchfelder M, Klibanski A, Laws ER, Loeffler JS, et al. On behalf of the pituitary society, expert group on pituitary tumors ()read criteria on pituitary tumour centers of excellence: a pituitary society statement. Pituitary. 2017;20:489–98. https://doi.org/10.1007/s11102-017-0838-2.CrossRef Casanueva FF, Barkan AL, Buchfelder M, Klibanski A, Laws ER, Loeffler JS, et al. On behalf of the pituitary society, expert group on pituitary tumors ()read criteria on pituitary tumour centers of excellence: a pituitary society statement. Pituitary. 2017;20:489–98. https://​doi.​org/​10.​1007/​s11102-017-0838-2.CrossRef
go back to reference Crona J, Taieb D, Pacak K. New perspectives on pheochromcytoma and paraganglioma: toward a molecular classification. Endocr Rev. 2017;38:489–515.CrossRef Crona J, Taieb D, Pacak K. New perspectives on pheochromcytoma and paraganglioma: toward a molecular classification. Endocr Rev. 2017;38:489–515.CrossRef
go back to reference Dasgupta B, et al. Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors. Cancer Res. 2005;65:2755–60.CrossRef Dasgupta B, et al. Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors. Cancer Res. 2005;65:2755–60.CrossRef
go back to reference De Laat JM, Van der Luijt RB, Pieterman CR, Oostveen MP, Hermus AR, Dekkers OM, et al. MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients. BMC Med. 2016 Nov 15;14(1):182. De Laat JM, Van der Luijt RB, Pieterman CR, Oostveen MP, Hermus AR, Dekkers OM, et al. MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients. BMC Med. 2016 Nov 15;14(1):182.
go back to reference Eng C. PTEN hamartoma tumor syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington; 1993–2019. [updated 2016 Jun 2]. Eng C. PTEN hamartoma tumor syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington; 1993–2019. [updated 2016 Jun 2].
go back to reference Fassnacht M, Assie A, Baudin E, et al. Adrenocortical carcinomas and malignant pheochromocytomas: ESMO-EuRaCan-EndoERN clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. [Submitted]. Fassnacht M, Assie A, Baudin E, et al. Adrenocortical carcinomas and malignant pheochromocytomas: ESMO-EuRaCan-EndoERN clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. [Submitted].
go back to reference Fassnacht M, Dekkers O, Else T, et al. European society of endocrinology clinical practice guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European network for the study of adrenal tumors. Eur J Endocrinol. 2018 Jul 24;pii:EJE-18-0608. Fassnacht M, Dekkers O, Else T, et al. European society of endocrinology clinical practice guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European network for the study of adrenal tumors. Eur J Endocrinol. 2018 Jul 24;pii:EJE-18-0608.
go back to reference Feelders RA, Newell-Price J, Pivonello R, Nieman LK, Hofland LJ, Lacroix A. Advances in the medical treatment of Cushing’s syndrome. Lancet Diabetes Endocrinol. 2019;7(4):300–12.CrossRef Feelders RA, Newell-Price J, Pivonello R, Nieman LK, Hofland LJ, Lacroix A. Advances in the medical treatment of Cushing’s syndrome. Lancet Diabetes Endocrinol. 2019;7(4):300–12.CrossRef
go back to reference Fishbein L, Leshchiner I, Walter V, Danilova A, Robertson AG, Johnson AR, et al. Cancer genome atlas research network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017;31(2):181–93. Fishbein L, Leshchiner I, Walter V, Danilova A, Robertson AG, Johnson AR, et al. Cancer genome atlas research network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017;31(2):181–93.
go back to reference Freda PU, Beckers AM, Katznelson L, Molitch ME, Montori VM, Post KD, Vance ML. Read guideline on pituitary incidentaloma. J Clin Endocrinol Metab. 2011;96(4):894–904.CrossRef Freda PU, Beckers AM, Katznelson L, Molitch ME, Montori VM, Post KD, Vance ML. Read guideline on pituitary incidentaloma. J Clin Endocrinol Metab. 2011;96(4):894–904.CrossRef
go back to reference Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(5):1889–916. Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(5):1889–916.
go back to reference Gutmann DH, et al. Neurofibromatosis type 1. Nat Rev Dis Primers. 2017;23(3):17004.CrossRef Gutmann DH, et al. Neurofibromatosis type 1. Nat Rev Dis Primers. 2017;23(3):17004.CrossRef
go back to reference Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133. https://doi.org/10.1089/thy.2015.0020.CrossRef Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133. https://​doi.​org/​10.​1089/​thy.​2015.​0020.CrossRef
go back to reference Hofland J, Zandee WT, De Herder WW. Role of biomarker tests for diagnosis of neuroendocrine tumours. Nat Rev Endocrinol. 2018;14:656–69.CrossRef Hofland J, Zandee WT, De Herder WW. Role of biomarker tests for diagnosis of neuroendocrine tumours. Nat Rev Endocrinol. 2018;14:656–69.CrossRef
go back to reference Katznelson L, Laws ER, Melmed S, Molitch ME, Hassan Murad M, Utz A, Wass JAH. Read guideline on Acromegaly. J Clin Endocrinol Metab. 2014;99(11):3933–51.CrossRef Katznelson L, Laws ER, Melmed S, Molitch ME, Hassan Murad M, Utz A, Wass JAH. Read guideline on Acromegaly. J Clin Endocrinol Metab. 2014;99(11):3933–51.CrossRef
go back to reference Lacroix A, Feelders RA, Stratakis CA, Nieman LK. Cushing’s syndrome. Lancet. 2015 Aug 29;386(9996):913–27. Lacroix A, Feelders RA, Stratakis CA, Nieman LK. Cushing’s syndrome. Lancet. 2015 Aug 29;386(9996):913–27.
go back to reference Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, et al.; Endocrine Society. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915–42. Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, et al.; Endocrine Society. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915–42.
go back to reference Mehta A, et al. Hyperparathyroidism-jaw tumor syndrome: results of surgical management. Surgery. 2014;156(6):1315–25.CrossRef Mehta A, et al. Hyperparathyroidism-jaw tumor syndrome: results of surgical management. Surgery. 2014;156(6):1315–25.CrossRef
go back to reference Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, Wass JAH. Read guideline on diagnosis and treatment of hyperprolactinemia. J Clin Endocrinol Metab. 2011;96(2):273–88.CrossRef Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, Wass JAH. Read guideline on diagnosis and treatment of hyperprolactinemia. J Clin Endocrinol Metab. 2011;96(2):273–88.CrossRef
go back to reference Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO, Tabarin A; Endocrine Society. Treatment of Cushing’s Syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(8):2807–31. Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO, Tabarin A; Endocrine Society. Treatment of Cushing’s Syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(8):2807–31.
go back to reference Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM. The diagnosis of Cushing’s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93(5):1526–40.CrossRef Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM. The diagnosis of Cushing’s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93(5):1526–40.CrossRef
go back to reference Neumann HP, Young WF Jr, Krauss T, Bayley JP, Schiavi F, Opocher G, et al. 65 Years of the double helix: genetics informs precision practice in the diagnosis and management of pheochromocytoma. Endocr Relat Cancer. 2018;25(8):T201–19. [Epub 2018 May 24]. Neumann HP, Young WF Jr, Krauss T, Bayley JP, Schiavi F, Opocher G, et al. 65 Years of the double helix: genetics informs precision practice in the diagnosis and management of pheochromocytoma. Endocr Relat Cancer. 2018;25(8):T201–19. [Epub 2018 May 24].
go back to reference Pavel M, O’Toole D, Costa F, et al. ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial Neuroendocrine Neoplasms (NEN) and NEN of unknown primary site. Neuroendocrinology. 2016;103:172–85.CrossRef Pavel M, O’Toole D, Costa F, et al. ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial Neuroendocrine Neoplasms (NEN) and NEN of unknown primary site. Neuroendocrinology. 2016;103:172–85.CrossRef
go back to reference Raverot G, Burman P, McCormack A, Heaney A, Petersenn S, Popovic V, et al.; The European Society of Endocrinology. Read guideline on the management for the management of aggressive pituitary tumours and carcinomas. Eur J Endocrinol. 2018;178(1):G1–24. Raverot G, Burman P, McCormack A, Heaney A, Petersenn S, Popovic V, et al.; The European Society of Endocrinology. Read guideline on the management for the management of aggressive pituitary tumours and carcinomas. Eur J Endocrinol. 2018;178(1):G1–24.
go back to reference Raymond E, Dahan L, Raoul JL, et al. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med. 2011;364:501–13.CrossRef Raymond E, Dahan L, Raoul JL, et al. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med. 2011;364:501–13.CrossRef
go back to reference Steward AF. Hypercalcemia associated with cancer. N Engl J Med. 2005;352:373–9.CrossRef Steward AF. Hypercalcemia associated with cancer. N Engl J Med. 2005;352:373–9.CrossRef
go back to reference Stichting opsporing erfelijke tumoren (STOET), vereniging klinische genetica Nederland en werkgroep klinisch oncogenetica. Erfelijke en familiaire tumoren. Richtlijnen voor diagnostiek en preventie 2017 (zesde druk). www.stoet.nl. Stichting opsporing erfelijke tumoren (STOET), vereniging klinische genetica Nederland en werkgroep klinisch oncogenetica. Erfelijke en familiaire tumoren. Richtlijnen voor diagnostiek en preventie 2017 (zesde druk). www.​stoet.​nl.
go back to reference St-Jean M, Ghorayeb NE, Bourdeau I, Lacroix A. Aberrant G-protein coupled hormone receptor in adrenal diseases. Best Pract Res Clin Endocrinol Metab. 2018;32(2):165–87.CrossRef St-Jean M, Ghorayeb NE, Bourdeau I, Lacroix A. Aberrant G-protein coupled hormone receptor in adrenal diseases. Best Pract Res Clin Endocrinol Metab. 2018;32(2):165–87.CrossRef
go back to reference Stratakis CA, Raygada M. Carney complex. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington; 1993–2019. [updated 2018 Aug 16]. Stratakis CA, Raygada M. Carney complex. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington; 1993–2019. [updated 2018 Aug 16].
go back to reference Strosberg J, El-Haddad G, Wolin E, et al. Phase 3 trial of 177Lu-dotatate for midgut neuroendocrine tumors. N Engl J Med. 2017;376:125–35.CrossRef Strosberg J, El-Haddad G, Wolin E, et al. Phase 3 trial of 177Lu-dotatate for midgut neuroendocrine tumors. N Engl J Med. 2017;376:125–35.CrossRef
go back to reference Teh BT, Farnebo F, Kristoffersson U, Sundelin B, Cardinal J, Axelson R, et al. Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease; linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas. J Clin Endocrinol Metab. 1996;81(12):4204–11. Teh BT, Farnebo F, Kristoffersson U, Sundelin B, Cardinal J, Axelson R, et al. Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease; linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas. J Clin Endocrinol Metab. 1996;81(12):4204–11.
go back to reference Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, et al.; Endocrine Society. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab. 2012;97(9):2990–3011. https://doi.org/10.1210/jc.2012-1230. [Epub 2012 Jun 20]. Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, et al.; Endocrine Society. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab. 2012;97(9):2990–3011. https://​doi.​org/​10.​1210/​jc.​2012-1230. [Epub 2012 Jun 20].
go back to reference Van Leeuwaarde RS, Ahmad S, Links TP, Giles RH. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. Von Hippel-Lindau syndrome. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2019. 2000 May 17 [updated 2018 Sep 6]. Van Leeuwaarde RS, Ahmad S, Links TP, Giles RH. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. Von Hippel-Lindau syndrome. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2019. 2000 May 17 [updated 2018 Sep 6].
go back to reference Yao JC, Fazio N, Singh S, et al. Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study. Lancet. 2016;387:968–77.CrossRef Yao JC, Fazio N, Singh S, et al. Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study. Lancet. 2016;387:968–77.CrossRef
go back to reference Yao JC, Shah MH, Ito T, et al. Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med. 2011;364:514–23.CrossRef Yao JC, Shah MH, Ito T, et al. Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med. 2011;364:514–23.CrossRef
Metagegevens
Titel
Endocriene tumoren
Auteurs
Prof. dr. G. D. Valk
Dr. R. S. van Leeuwaarde
Dr. M. J. C. van Treijen
Prof. dr. T. P. Links
Prof. dr. R. P. Peeters
Dr. H. J. L. M. Timmers
Dr. E. P. M. van der Kleij-Corssmit
Prof. dr. O. M. Dekkers
Dr. R. A. Feelders
Prof. dr. H. R. Haak
Prof. dr. N. R. Biermasz
Dr. J. Hofland
Prof. dr. W. W. de Herder
Prof. dr. A. M. Pereira Arias
Em. prof. dr. P. T. A. M. Lips
Prof. dr. J. W. A. Smit
Prof. dr. C. J. M. Lips
Dr. H. W. Kapiteijn
Prof. dr. J. Kievit
H. F. ten Kroode
Copyright
2020
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-368-2449-1_30